ERBB2 and cancer: In this context, we found that the intrinsic sensitivity of the tested HER2+ GC cells to HER2 targeting is positively associated with the per se capability of anti-HER2 agents to impair gastrosphere formation; indeed, only low or no levels of GFE % inhibition were observed in T-resistant cell targets, confirming the existence of additional drivers supporting cancer stemness features.